Citations

Citations to this article as recorded by  

• Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer
  Brenno Pastò, Riccardo Vida, Arianna Dri, Lorenzo Foffano, Serena Della Rossa, Lorenzo Gerratana, Fabio Puglisi
  The Breast.2025; 79: 103859.     CrossRef
• Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
  Florencia P. Madorsky Rowdo, Rachel Martini, Sarah E. Ackermann, Colin P. Tang, Marvel Tranquille, Adriana Irizarry, Ilkay Us, Omar Alawa, Jenna E. Moyer, Michael Sigouros, John Nguyen, Majd Al Assaad, Esther Cheng, Paula S. Ginter, Jyothi Manohar, Brian
  Cancer Research.2025; 85(3): 551.     CrossRef
• Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling
  Matthew J. Regner, Susana Garcia-Recio, Aatish Thennavan, Kamila Wisniewska, Raul Mendez-Giraldez, Brooke Felsheim, Philip M. Spanheimer, Joel S. Parker, Charles M. Perou, Hector L. Franco
  Cell Genomics.2025; 5(2): 100765.     CrossRef
• Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in Luminal Patients
  Marianna Rita Brogna, Gerardo Ferrara, Valeria Varone, Angela Montone, MariaRosaria Schiano, Michele DelSesto, Francesca Collina
  Molecular Carcinogenesis.2025;[Epub]     CrossRef
• Imaging genomics of cancer: a bibliometric analysis and review
  Xinyi Gou, Aobo Feng, Caizhen Feng, Jin Cheng, Nan Hong
  Cancer Imaging.2025;[Epub]     CrossRef
• PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study
  Judith Katharina Ballé, Martina Vetter, Tariku Wakuma Kenea, Pia Eber-Schulz, Christian Reibold, Hannes-Viktor Ziegenhorn, Kathrin Stückrath, Claudia Wickenhauser, Adamu Addissie, Pablo Santos, Eva Johanna Kantelhardt, Sefonias Getachew, Marcus Bauer
  BMC Cancer.2024;[Epub]     CrossRef
• Migratory Tumor Cells Cooperate with Cancer Associated Fibroblasts in Hormone Receptor-Positive and HER2-Negative Breast Cancer
  Eun Hye Joo, Sangmin Kim, Donghyun Park, Taeseob Lee, Woong-Yang Park, Kyung Yeon Han, Jeong Eon Lee
  International Journal of Molecular Sciences.2024; 25(11): 5876.     CrossRef
• Discovery of a proliferation essential gene signature and actin‐like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple‐positive breast cancer
  Xiaofen Li, Shiping Luo, Wenfen Fu, Mingyao Huang, Xiewei Huang, Shaohong Kang, Jie Zhang, Qingshui Wang, Chuangui Song
  Cancer.2024; 130(S8): 1435.     CrossRef
• Breast Cancer Molecular Subtyping in Practice: A Real-World Study of the APIS Breast Cancer Subtyping Assay in a Consecutive Series of Breast Core Biopsies
  Silvana Di Palma, Panagiotis Koliou, Alex Simonovic, Daniela Costa, Catherine Faulkes, Brenda Kobutungi, Felicity Paterson, Jonathan David Horsnell, Farrokh Pakzad, Tracey Irvine, Polly Partlett, Elizabeth Clayton, Nadine Collins
  International Journal of Molecular Sciences.2024; 25(5): 2616.     CrossRef
• iCluF: an unsupervised iterative cluster-fusion method for patient stratification using multiomics data
  Sushil K Shakyawar, Balasrinivasa R Sajja, Jai Chand Patel, Chittibabu Guda, Marieke Kuijjer
  Bioinformatics Advances.2024;[Epub]     CrossRef
• Differences in Histological Subtypes of Invasive Lobular Breast Carcinoma According to Immunohistochemical Molecular Classification
  Ivan Ilić, Jana Cvetković, Ratko Ilić, Ljubiša Cvetković, Aleksandar Milićević, Stefan Todorović, Pavle Ranđelović
  Diagnostics.2024; 14(6): 660.     CrossRef
• Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study
  Tobias Berg, Maj-Britt Jensen, Alan Celik, Maj-Lis Talman, Maria Anna Misiakou, Ann Søegaard Knoop, Finn Cilius Nielsen, Bent Ejlertsen, Maria Rossing
  JCI Insight.2024;[Epub]     CrossRef
• Effect of internal subtype on the efficacy of CDK4/6 inhibitor therapy in advanced HR+/HER2breast cancer: A review
  Katerina S. Grechukhina, Daria A. Filonenko, Margarita V. Sukhova, Liudmila G. Zhukova
  Journal of Modern Oncology.2024; 26(2): 182.     CrossRef
• Clinicopathological characteristics, treatment patterns and outcomes in patients with HER2-positive breast cancer based on hormone receptor status: a retrospective study
  Ran Ran, Shidi Zhao, Yan Zhou, Xinyue Hang, Hui Wang, Yuan Fan, Yusi Zhang, Yifan Qiao, Jin Yang, Danfeng Dong
  BMC Cancer.2024;[Epub]     CrossRef
• LUCAT1-Mediated Competing Endogenous RNA (ceRNA) Network in Triple-Negative Breast Cancer
  Deepak Verma, Sumit Siddharth, Ashutosh S. Yende, Qitong Wu, Dipali Sharma
  Cells.2024; 13(22): 1918.     CrossRef
• Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data
  Kaiyuan Xing, Bo Zhang, Zixuan Wang, Yanru Zhang, Tengyue Chai, Jingkai Geng, Xuexue Qin, Xi Steven Chen, Xinxin Zhang, Chaohan Xu
  Cells.2023; 12(3): 367.     CrossRef
• Moanna: Multi-Omics Autoencoder-Based Neural Network Algorithm for Predicting Breast Cancer Subtypes
  Richard Lupat, Rashindrie Perera, Sherene Loi, Jason Li
  IEEE Access.2023; 11: 10912.     CrossRef
• Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
  Thérèse Dix-Peek, Boitumelo P. Phakathi, Eunice J. van den Berg, Caroline Dickens, Tanya N. Augustine, Herbert Cubasch, Alfred I. Neugut, Judith S. Jacobson, Maureen Joffe, Paul Ruff, Raquel A. B. Duarte
  Breast Cancer Research and Treatment.2023; 199(1): 1.     CrossRef
• A Simple Method for Robust and Accurate Intrinsic Subtyping of Breast Cancer
  Mehdi Hamaneh, Yi-Kuo Yu
  Cancer Informatics.2023;[Epub]     CrossRef
• XAI-MethylMarker: Explainable AI approach for biomarker discovery for breast cancer subtype classification using methylation data
  Sheetal Rajpal, Ankit Rajpal, Arpita Saggar, Ashok K. Vaid, Virendra Kumar, Manoj Agarwal, Naveen Kumar
  Expert Systems with Applications.2023; 225: 120130.     CrossRef
• XAI-CNVMarker: Explainable AI-based copy number variant biomarker discovery for breast cancer subtypes
  Sheetal Rajpal, Ankit Rajpal, Manoj Agarwal, Virendra Kumar, Ajith Abraham, Divya Khanna, Naveen Kumar
  Biomedical Signal Processing and Control.2023; 84: 104979.     CrossRef
• The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
  Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, Dora Natalini, Alessio Piccolantonio, Pietro Arina, Alessandro Morellato, Ugo Ala, Daniela Taverna, Emilia Turco, Paola Defilippi
  Frontiers in Oncology.2023;[Epub]     CrossRef
• HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping
  Coralia Bueno Muiño, Miguel Martín, María del Monte-Millán, José Ángel García-Saénz, Sara López-Tarruella
  Cancers.2022; 14(3): 512.     CrossRef
• Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab
  Fanfan Li, Qian Ju, Cong Gao, Jingjing Li, Xiaolei Wang, Min Yan, Liying Zhang, Meiling Huang, Qihe Long, Xiangting Jin, Nanlin Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer
  Xinyu Ren, Yu Song, Yanna zhang, Huanwen Wu, Longyun Chen, Junyi Pang, Liangrui Zhou, Songjie Shen, Zhiyong Liang
  BMC Cancer.2022;[Epub]     CrossRef
• Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
  Ramona Erber, Miriam Angeloni, Robert Stöhr, Michael P. Lux, Daniel Ulbrich-Gebauer, Enrico Pelz, Agnes Bankfalvi, Kurt W. Schmid, Robert F. H. Walter, Martina Vetter, Christoph Thomssen, Doris Mayr, Frederick Klauschen, Peter Sinn, Karl Sotlar, Katharina
  International Journal of Molecular Sciences.2022; 23(15): 8716.     CrossRef
• The Current Staging and Classification Systems of Breast Cancer and Their Pitfalls: Is It Possible to Integrate the Complexity of this Neoplasm into a Unified Staging System?
  Felipe Andrés Cordero da Luz, Breno Jeha Araújo, Rogério Agenor de Araújo
  Critical Reviews in Oncology/Hematology.2022; : 103781.     CrossRef
• Prognostic factors and molecular subtypes in young women with breast cancer
  Yasmin Shukair, Rafaela Veiga Monteiro
  Mastology.2022;[Epub]     CrossRef
• Understanding Breast Cancers through Spatial and High-Resolution Visualization Using Imaging Technologies
  Haruko Takahashi, Daisuke Kawahara, Yutaka Kikuchi
  Cancers.2022; 14(17): 4080.     CrossRef
• Risk Stratification for Breast Cancer Patient by Simultaneous Learning of Molecular Subtype and Survival Outcome Using Genetic Algorithm-Based Gene Set Selection
  Bonil Koo, Dohoon Lee, Sangseon Lee, Inyoung Sung, Sun Kim, Sunho Lee
  Cancers.2022; 14(17): 4120.     CrossRef
• Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers
  Yingying Xu, Yonghao Liang, Guanghao Yin
  Clinical and Translational Oncology.2022; 25(4): 1024.     CrossRef
• Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
  Marcela Carausu, Matthieu Carton, Véronique Diéras, Thierry Petit, Séverine Guiu, Anthony Gonçalves, Paule Augereau, Jean Marc Ferrero, Christelle Levy, Mony Ung, Isabelle Desmoulins, Marc Debled, Thomas Bachelot, Barbara Pistilli, Jean-Sébastien Frenel,
  JAMA Network Open.2022; 5(12): e2247154.     CrossRef
• Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review
  Ran Ran, Yingying Ma, Hui Wang, Jin Yang, Jiao Yang
  Frontiers in Oncology.2022;[Epub]     CrossRef
• PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study
  Lin Wang, Qian Li, Vasily N. Aushev, Alfred I. Neugut, Regina M. Santella, Susan Teitelbaum, Jia Chen
  Breast Cancer.2021; 28(6): 1235.     CrossRef
• Triphasic DeepBRCA-A Deep Learning-Based Framework for Identification of Biomarkers for Breast Cancer Stratification
  Sheetal Rajpal, Manoj Agarwal, Virendra Kumar, Anamika Gupta, Naveen Kumar
  IEEE Access.2021; 9: 103347.     CrossRef
• Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level
  Yan Zhang, Denan Zhang, Qingkang Meng, Ziqi Liu, Hongbo Xie, Lei Liu, Fei Xu, Xiujie Chen
  BMC Cancer.2021;[Epub]     CrossRef
• A single-cell and spatially resolved atlas of human breast cancers
  Sunny Z. Wu, Ghamdan Al-Eryani, Daniel Lee Roden, Simon Junankar, Kate Harvey, Alma Andersson, Aatish Thennavan, Chenfei Wang, James R. Torpy, Nenad Bartonicek, Taopeng Wang, Ludvig Larsson, Dominik Kaczorowski, Neil I. Weisenfeld, Cedric R. Uytingco, Jen
  Nature Genetics.2021; 53(9): 1334.     CrossRef
• Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method
  Junmei Hao, Yan Lyu, Jiarui Zou, Yunyun Zhang, Shuishan Xie, Lili Jing, Fangrong Tang, Jiahong Lyu, Wenfeng Zhang, Jianbo Zhang, Xunting Wang, Kuisheng Chen, Jiandi Zhang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Poor histologic tumor response after adjuvant therapy in basal-like HER2-positive breast carcinoma
  Danhui Zhao, Xin Fu, Joseph Rohr, Yingmei Wang, Mingyang Li, Xiuming Zhang, Junhui Qin, Mengwei Xu, Chao Li, Guorui Sun, Zhe Wang, Shuangping Guo
  Pathology - Research and Practice.2021; 228: 153677.     CrossRef
• Moving beyond endocrine therapy for luminal metastatic breast cancer in the precision medicine era: looking for new targets
  Stefania Morganti, Giuseppe Curigliano
  Expert Review of Precision Medicine and Drug Development.2020; 5(1): 7.     CrossRef
• MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
  Elise Klæstad, Signe Opdahl, Monica Jernberg Engstrøm, Borgny Ytterhus, Elisabeth Wik, Anna Mary Bofin, Marit Valla
  Breast Cancer Research and Treatment.2020; 180(1): 73.     CrossRef
• Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Liuwen Yu, Fangmeng Fu, Jing Li, Meng Huang, Bangwei Zeng, Yuxiang Lin, Qian Mei, Jinxing Lv, Chuan Wang
  Journal of Oncology.2020; 2020: 1.     CrossRef
• Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape
  Seokhyun Yoon, Hye Sung Won, Keunsoo Kang, Kexin Qiu, Woong June Park, Yoon Ho Ko
  Cancers.2020; 12(5): 1165.     CrossRef
• Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?
  Jing Yu, Jiayi Wu, Ou Huang, Jianrong He, Zhu Li, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
  Frontiers in Oncology.2020;[Epub]     CrossRef
• DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer
  Lei Lei, Xiao-Jia Wang, Yin-Yuan Mo, Skye Hung-Chun Cheng, Yunyun Zhou
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Subtype-specific risk models for accurately predicting the prognosis of breast cancer using differentially expressed autophagy-related genes
  Baoai Han, He Zhang, Yuying Zhu, Xingxing Han, Zhiyong Wang, Zicong Gao, Yue Yuan, Ruinan Tian, Fei Zhang, Ruifang Niu
  Aging.2020; 12(13): 13318.     CrossRef
• Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
  Ji-Yeon Kim, Kyunghee Park, Seock-Ah Im, Kyung Hae Jung, Joohyuk Sohn, Keun Seok Lee, Jee Hyun Kim, Yaewon Yang, Yeon Hee Park
  Breast Cancer Research and Treatment.2020; 184(3): 743.     CrossRef
• Quantification of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Protein Expression in Bone Biopsies by Targeted Mass Spectrometry without Acid Decalcification
  Regine M Schoenherr, Uliana J Voytovich, Jeffrey R Whiteaker, Vijayakrishna K Gadi, Julie R Gralow, Amanda G Paulovich
  Clinical Chemistry.2020; 66(11): 1459.     CrossRef
• A Topic Modeling Analysis of TCGA Breast and Lung Cancer Transcriptomic Data
  Filippo Valle, Matteo Osella, Michele Caselle
  Cancers.2020; 12(12): 3799.     CrossRef
• Treatment selection for patients with equivocal HER2 status and in luminal versus HER2-enriched disease
  Giuseppe Viale, Elisabetta Munzone
  The Breast.2019; 48: S49.     CrossRef